Walid Abi-Saab
Chief Tech/Sci/R&D Officer bij UNIQURE N.V.
Vermogen: 606 840 $ op 31-03-2024
Profiel
Dr. Walid Abi-Saab, MD, is Chief Medical Officer bij Galapagos NV. Dr. Abi-Saab was voorheen werkzaam als Group Vice President-Clinical Development bij Shire Plc en als Assistant Professor-Psychiatry & Neurosurgery bij Yale School of Medicine. Hij behaalde zijn doctoraat aan de Universiteit van Saint Joseph (Macau).
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
UNIQURE N.V.
0.24% | 01-03-2024 | 116 700 ( 0.24% ) | 606 840 $ | 31-03-2024 |
Actieve functies van Walid Abi-Saab
| Bedrijven | Functie | Begin |
|---|---|---|
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 26-06-2023 |
Eerdere bekende functies van Walid Abi-Saab
| Bedrijven | Functie | Einde |
|---|---|---|
| GALAPAGOS NV | Chief Tech/Sci/R&D Officer | 31-12-2022 |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| Yale School of Medicine | Corporate Officer/Principal | - |
Opleiding van Walid Abi-Saab
| American University of Beirut | Undergraduate Degree |
| Université Saint-Joseph | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| UNIQURE N.V. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
